(20)Commission Implementing Regulation (EU) 2023/689note extended the approval period of trinexapac to 15 December 2024 in order to allow the renewal process to be completed before the expiry of the approval period of that active substance. However, given that a decision on the renewal of the approval of that active substance has been taken ahead of that extended expiry date, this Regulation should apply earlier than that date.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.